SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-001933
Filing Date
2009-02-27
Accepted
2009-02-27 10:06:54
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 EXHIBIT 10-K a2190879z10-k.htm 10-K 1314855
2 EXHIBIT 10.12 a2190879zex-10_12.htm EX-10.12 4733
3 EXHIBIT 21.1 a2190879zex-21_1.htm EX-21.1 1944
4 EXHIBIT 23.1 a2190879zex-23_1.htm EX-23.1 3210
5 EXHIBIT 31.1 a2190879zex-31_1.htm EX-31.1 7728
6 EXHIBIT 31.2 a2190879zex-31_2.htm EX-31.2 7797
7 EXHIBIT 32.1 a2190879zex-32_1.htm EX-32.1 4013
8 EXHIBIT 32.2 a2190879zex-32_2.htm EX-32.2 4103
9 G390710.JPG g390710.jpg GRAPHIC 5330
  Complete submission text file 0001047469-09-001933.txt   1357362
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14732 | Film No.: 09640056
SIC: 2835 In Vitro & In Vivo Diagnostic Substances